Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Karman Line Memory Strategy Training, a Combined Computerized and Face-to-face Compensatory Treatment Targeting Memory Complaints After Acquired Brain Injury, Using Single-case Experimental Design Methodology

NCT06774287 is registered in ClinicalTrials.gov with Klimmendaal Revalidatiespecialisten as lead sponsor.

NCT NCT06774287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06774287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Karman Line Memory Strategy Training, a Combined Computerized and Face-to-face Compensatory Treatment Targeting Memory Complaints After Acquired Brain Injury, Using Single-case Experimental Design Methodology
Lead sponsor
Klimmendaal Revalidatiespecialisten
Phase
Not applicable
Overall status
Completed
Start date
January 21, 2025
Completion date
April 15, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired brain injury (including stroke)